KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Emergent BioSolutions (EBS) Shares Outstanding: 2010-2014

  • Emergent BioSolutions' Shares Outstanding rose 26.06% to $29,181.5 billion in Q4 2014 from the same period last year, while for Dec 2014 it was $29,181.5 billion, marking a year-over-year increase of 26.06%. This contributed to the annual value of $29,181.5 billion for FY2014, which is 26.06% up from last year.
  • Emergent BioSolutions' Shares Outstanding amounted to $29,181.5 billion in Q4 2014, which was up 26.06% from $23,148.7 billion recorded in Q4 2013.
  • Emergent BioSolutions' Shares Outstanding's 5-year high stood at $29,181.5 billion during Q4 2014, with a 5-year trough of $6,060.6 billion in Q2 2010.
  • Its 2-year average for Shares Outstanding is $26,165.1 billion, with a median of $26,165.1 billion in 2013.
  • Data for Emergent BioSolutions' Shares Outstanding shows a peak YoY increased of 26.06% (in 2014) over the last 5 years.
  • Emergent BioSolutions' Shares Outstanding (Quarterly) stood at $6,679.7 billion in 2010, then reached $23,148.7 billion in 2013, then climbed by 26.06% to $29,181.5 billion in 2014.
  • Its last three reported values are $29,181.5 billion in Q4 2014, $23,148.7 billion for Q4 2013, and $6,679.7 billion during Q3 2010.